Polysaccharide-decorated nanoparticles

被引:397
作者
Lemarchand, C
Gref, R
Couvreur, P
机构
[1] Univ Paris 11, Fac Pharm, Sch Pharm, CNRS,UMR 8612, F-92926 Chatenay Malabry, France
[2] BioAlliance Pharma, Paris, France
关键词
nanoparticles; polysaccharide; surface modification; surface characterization; cancer therapy; tumour imaging; mucoadhesion; targeting;
D O I
10.1016/j.ejpb.2004.02.016
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Surface modified colloidal carriers such as nanoparticles are able to modulate the biodistribution of the loaded drug when given intravenously, but also to control the absorption of drugs administered by other routes. This review presents the different strategies to coat the surface of polymeric as well as inorganic nanoparticles with polysaccharides. Various physicochemical and biological methods have been described to demonstrate such surface modification. The medical applications, mainly in imaging cancer, of polysaccharide-coated nanoparticles are presented, including their abilities to increase the blood circulation time and to target specific tumoral tissues. It has been shown that these coatings allow also to improve drug absorption via nasal or ocular pathways, due the mucoadhesive and/or permeability enhancer properties of the poly saccharides. Finally, the ability of polysaccharide-coated nanoparticles to deliver DNA or oligonucleotides will be discussed. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:327 / 341
页数:15
相关论文
共 111 条
[1]  
ABOUBAKAR M, 2003, Patent No. 0301909
[2]   Self-assembled hydrogel nanoparticle of cholesterol-bearing pullulan as a carrier of protein drugs: Complexation and stabilization of insulin [J].
Akiyoshi, K ;
Kobayashi, S ;
Shichibe, S ;
Mix, D ;
Baudys, M ;
Kim, SW ;
Sunamoto, J .
JOURNAL OF CONTROLLED RELEASE, 1998, 54 (03) :313-320
[3]  
Akiyoshi K., 1996, SUPRAMOL SCI, V3, P157, DOI [10.1016/0968-5677(96)00031-4, DOI 10.1016/0968-5677(96)00031-4]
[4]   THE USE OF GLYCOLIPIDS AND HYDROPHILIC POLYMERS IN AVOIDING RAPID UPTAKE OF LIPOSOMES BY THE MONONUCLEAR PHAGOCYTE SYSTEM [J].
ALLEN, TM .
ADVANCED DRUG DELIVERY REVIEWS, 1994, 13 (03) :285-309
[5]   EFFECT OF CHITOSAN ON THE PERMEABILITY OF MONOLAYERS OF INTESTINAL EPITHELIAL-CELLS (CACO-2) [J].
ARTURSSON, P ;
LINDMARK, T ;
DAVIS, SS ;
ILLUM, L .
PHARMACEUTICAL RESEARCH, 1994, 11 (09) :1358-1361
[6]   Design of poly-ε-caprolactone nanospheres coated with bioadhesive hyaluronic acid for ocular delivery [J].
Barbault-Foucher, S ;
Gref, R ;
Russo, P ;
Guechot, J ;
Bochot, A .
JOURNAL OF CONTROLLED RELEASE, 2002, 83 (03) :365-375
[7]   Colloidal drug carriers: achievements and perspectives [J].
Barratt, G .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2003, 60 (01) :21-37
[8]   STEALTH ME.PEG-PLA NANOPARTICLES AVOID UPTAKE BY THE MONONUCLEAR PHAGOCYTES SYSTEM [J].
BAZILE, D ;
PRUDHOMME, C ;
BASSOULLET, MT ;
MARLARD, M ;
SPENLEHAUER, G ;
VEILLARD, M .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1995, 84 (04) :493-498
[9]   Dextran and albumin derivatised iron oxide nanoparticles: influence on fibroblasts in vitro [J].
Berry, CC ;
Wells, S ;
Charles, S ;
Curtis, ASG .
BIOMATERIALS, 2003, 24 (25) :4551-4557
[10]   Superparamagnetic agents in magnetic resonance imaging: Physicochemical characteristics and clinical applications - A review [J].
Bonnemain, B .
JOURNAL OF DRUG TARGETING, 1998, 6 (03) :167-174